| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.0009 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.001 |